Patents by Inventor Josh Garretson

Josh Garretson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Embolic devices
    Patent number: 10232089
    Abstract: Described herein are apparatus, compositions, systems and associated methods to occlude structures and malformations of the vasculature with radiopaque hydrogel filaments with delayed controlled rates of expansion. Further described is a device for implantation in an animal comprising a difunctional, low molecular weight ethylenically unsaturated shapeable macromer; an ethylenically unsaturated monomer; and a radiopaque element, wherein said device contains no support members. Methods of forming such devices are also disclosed.
    Type: Grant
    Filed: August 30, 2016
    Date of Patent: March 19, 2019
    Assignee: Terumo Corporation
    Inventors: Michael Constant, Josh Garretson, Gregory M. Cruise
  • EMBOLIC DEVICES
    Publication number: 20160367730
    Abstract: Described herein are apparatus, compositions, systems and associated methods to occlude structures and malformations of the vasculature with radiopaque hydrogel filaments with delayed controlled rates of expansion. Further described is a device for implantation in an animal comprising a difunctional, low molecular weight ethylenically unsaturated shapeable macromer; an ethylenically unsaturated monomer; and a radiopaque element, wherein said device contains no support members. Methods of forming such devices are also disclosed.
    Type: Application
    Filed: August 30, 2016
    Publication date: December 22, 2016
    Inventors: Michael Constant, Josh Garretson, Gregory M. Cruise
  • Embolic devices
    Patent number: 9456823
    Abstract: Described herein are apparatus, compositions, systems and associated methods to occlude structures and malformations of the vasculature with radiopaque hydrogel filaments with delayed controlled rates of expansion. Further described is a device for implantation in an animal comprising a difunctional, low molecular weight ethylenically unsaturated shapeable macromer; an ethylenically unsaturated monomer; and a radiopaque element, wherein said device contains no support members. Methods of forming such devices are also disclosed.
    Type: Grant
    Filed: April 18, 2012
    Date of Patent: October 4, 2016
    Assignee: Terumo Corporation
    Inventors: Michael Constant, Josh Garretson, Gregory M. Cruise
  • EMBOLIC DEVICES
    Publication number: 20120289995
    Abstract: Described herein are apparatus, compositions, systems and associated methods to occlude structures and malformations of the vasculature with radiopaque hydrogel filaments with delayed controlled rates of expansion. Further described is a device for implantation in an animal comprising a difunctional, low molecular weight ethylenically unsaturated shapeable macromer; an ethylenically unsaturated monomer; and a radiopaque element, wherein said device contains no support members. Methods of forming such devices are also disclosed.
    Type: Application
    Filed: April 18, 2012
    Publication date: November 15, 2012
    Applicant: MICROVENTION, INC.
    Inventors: Michael Constant, Josh Garretson, Gregory M. Cruise